Consonance Capital Management LP Actinium Pharmaceuticals, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$7.62 - $9.79 $673,821 - $865,710
-88,428 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$7.8 - $12.64 $5.5 Million - $8.91 Million
-704,742 Reduced 88.85%
88,428 $690,000
Q3 2020

Nov 16, 2020
BUY
$7.26 - $18.0 $5.76 Million - $14.3 Million
793,170 New
793,170 $7.69 Million

Others Institutions Holding ATNM

# of Institutions
76
Shares Held
7.85M
Call Options Held
96.6K
Put Options Held
70.5K
View Full List

About Actinium Pharmaceuticals, Inc.

ATNM Quotes by TradingView
  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $45.3M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email